5,N-dimethyl-N-isopropyltryptamine

5,N-dimethyl-N-isopropyltryptamine

File:5-Me-MIPT.svg
Gene therapy
Clinical data
Physiological data
Legal status
Pharmacokinetic data
Identifiers
IUPAC name isopropyl-(2-(1H-indol-3-yl)-ethyl)-methylamine
Chemical and physical data
Formula	C15H22N2
Molar mass	230.36 g/mol

5,N-dimethyl-N-isopropyltryptamine (5-Me-MIPT) is a tryptamine derivative that is thought to be a hallucinogenic drug. It was first made in 1989. In vitro binding experiments on brain homogenates showed it to have a binding affinity between that of MIPT and 5-MeO-MIPT, both of which are known to be active hallucinogens in humans.